Vocabulary for Chromatography Column Packing
July 30, 2020 - Cytiva
Packing a chromatography column is an art in itself and requires a certain level of expertise. Here, we provide definitions for common terminology used in column pac…
Production of Recombinant Adeno-associated Virus Vectors Using Mi…
July 30, 2020 - Cytiva
As of March 2020, more than 4310 gene therapy clinical trials have been performed worldwide, with only 518 of them in Phase III and Phase IV. As the gene therapy pro…
Lentiviral Vector Upstream Process in Single-use Bioreactors
July 30, 2020 - Cytiva
Lentiviruses exhibit many desirable properties as gene transfer vehicles, such as high transduction efficiencies, ability to infect both dividing and nondividing c…
Pairing Data Connectivity and Comprehensive Automation
July 30, 2020 - Cytiva
In the biopharma industry, process data are used in many ways throughout process development and the different production phases. Learn more about Cytiva’s autom…
Improving mAb Manufacturing Productivity by Optimizing Buffer and…
July 30, 2020 - BioPharm International
Innovative approaches, including ready-to-use materials and in-line dilution, can significantly streamline overall bioprocessing operations.
By: Pranav Vengs…
Understanding and Controlling Raw Material Variation in Cell Cult…
July 16, 2020 - Cytiva
Manage variability through advanced analytical methods and risk-based assessment.
Click here to read more >>
Controlling Cell Culture Process Variability Through Supplier-Ena…
July 16, 2020 - Cytiva
In drug development and manufacturing, variability in raw materials presents high risks to the success of processes and products. When raw material variability issue…
Eliminating Residual Impurities Starts with a Strategic Plan
July 16, 2020 - BioPharm International
Eliminating Residual Impurities Starts with a Strategic Plan
Identifying the source, assessing the risk, and removing residual impurities requires a strategic appr…
Next Generation Process Chromatography
July 16, 2020 - Cytiva
Chromatography is an essential part in the production of all biopharmaceuticals. Without it the industry would not be able to produce therapeutics in an economic m…
Step Up to GMP Manufacturing or Outsource to a CDMO: Consideratio…
July 2, 2020 - Cytiva
Whether you are developing a new monoclonal antibody (mAb), cell therapy, gene therapy, or large-molecule biologic drug, the decision to tackle GMP manufacturing in-…